|
|
 | | | |
- close
- close
- close
- close
Halozyme Therapeutics (HALO) |
StreetInsider.com
May 23
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Halozyme+%28HALO%29+Names+David+Ramsay+as+CFO/8364553.html for the full story.
StreetInsider.com
May 17
Comment
Aruba Networks, Inc. (NASDAQ: ARUN) 27% LOWER; reported Q3 EPS of $0.11, $0.04 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $147.1 million versus the consensus estimate of $154.59 million. Sees Q4 revenue of $148...
Benzinga
May 16
Comment
Toward the end of trading Thursday, the Dow was down 0.10 percent to 15,259.91, while the NASDAQ rose 0.13 percent to 3,476.15. The S&P traded down, falling 0.23 percent to 1,654.47.
Top Headline
US stocks saw some volatility on Thursday,...
Benzinga
May 15
Comment
Piper Jaffray analyst Charles Duncan published report on Halozyme Therapeutics (NASDAQ: HALO) that initiated coverage on the stock with an Overweight rating and $10.00 price target.
In the report, Piper Jaffray reported that, "the company's...
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Halozyme+Therapeutics%2C+Inc.+%28HALO%29+Posts+Q1+Loss+of+17cShare/8319463.html for the full story.
Forbes
May 6
Comment
Halozyme Therapeutics, Inc. (HALO) reports its first quarter earnings on Wednesday, May 8, 2013.
StreetInsider.com
Mar 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Halozyme+%28HALO%29+Adds+Illumina+%28ILMN%29+Exec+to+Board/8218670.html for the full story.
StreetInsider.com
Mar 22
Comment
Crossing and above:
BlckBerry (Nasdaq: BBRY) - down 7.6 percent. BlackBerry did manage to dip below and get back above its 50-day SMA today following the launch of its Z10 handset. The 50-day is currently calculated at $14.72.
Apple, inc....
Benzinga
Mar 22
Comment
Baxter International (NYSE: BAX) and Halozyme Therapeutics (NASDAQ: HALO) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (EMA CHMP) has granted a Positive Opinion to Baxter for the use of HyQvia...
StreetInsider.com
Feb 25
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Halozyme+Therapeutics%2C+Inc.+%28HALO%29+Posts+Q4+Loss+of+4cShare/8129640.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
